(Q33384087)

26 July 2017

title

Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan (English)

1 reference

26 July 2017

6

Daniel Batlle

1 reference

26 July 2017

2

Minghao Ye

1 reference

26 July 2017

1

María José Soler

1 reference

26 July 2017

Jan Wysocki

3

1 reference

26 July 2017

Josette William

series ordinal

4

1 reference

26 July 2017

Josep Lloveras

series ordinal

5

1 reference

26 July 2017

publication date

12 November 2008

1 reference

American Journal of Physiology - Renal Physiology

26 July 2017

published in

1 reference

26 July 2017

volume

296

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

F398-405

1 reference

Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Renal protection: are all antihypertensive drugs comparable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Myocardial infarction increases ACE2 expression in rat and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Angiotensin II and the heart : on the intracrine renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Just the beginning: novel functions for angiotensin-converting enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

ACE2: a new target for cardiovascular disease therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Angiotensin-(1-7): an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Kinetics of the reaction of renin with nine synthetic peptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

ACE and ACE2 activity in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90488.2008

10.1152/AJPRENAL.90488.2008

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference